Cargando…
Siglecs as Therapeutic Targets in Cancer
SIMPLE SUMMARY: Hyperglycosylated cancer cells are often decorated with abundant sialic acids, which are recognized by Sialic acid binding immunoglobulin type lectins (Siglecs) expressed on immune cells. As sialic acids are normally expressed on almost all cell types, Siglecs can function as recepto...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8615218/ https://www.ncbi.nlm.nih.gov/pubmed/34827170 http://dx.doi.org/10.3390/biology10111178 |